Charles River Laboratories International Inc.’s recently made public that its EVP, Corp Strategy & Develop LaPlume Joseph W unloaded Company’s shares for reported $0.35 million on Aug 08 ’24. In the deal valued at $199.36 per share,1,780 shares were sold. As a result of this transaction, LaPlume Joseph W now holds 22,521 shares worth roughly $4.1 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Joseph LaPlume bought 1,780 shares, generating $350,000 in total proceeds.
Before that, FOSTER JAMES C sold 25,000 shares. Charles River Laboratories International Inc. shares valued at $6,250,000 were divested by the Chairman, President and CEO at a price of $250.00 per share. As a result of the transaction, FOSTER JAMES C now holds 188,251 shares, worth roughly $34.28 million.
CLSA initiated its Charles River Laboratories International Inc. [CRL] rating to an Underperform in a research note published on October 23, 2024; the price target was $167. A number of analysts have revised their coverage, including Redburn Atlantic’s analysts, who began to cover the stock in mid October with a ‘”a Sell”‘ rating. Evercore ISI also remained covering CRL and has decreased its forecast on October 07, 2024 with a “an In-line” recommendation from previously “an Outperform” rating. BofA Securities revised its rating on October 02, 2024. It rated CRL as “a Neutral” which previously was an “a Buy”.
Price Performance Review of CRL
On Friday, Charles River Laboratories International Inc. [NYSE:CRL] saw its stock fall -0.33% to $182.12. Over the last five days, the stock has lost -7.91%. Charles River Laboratories International Inc. shares have fallen nearly -22.96% since the year began. Nevertheless, the stocks have risen 5.46% over the past one year. While a 52-week high of $275.00 was reached on 03/08/24, a 52-week low of $161.65 was recorded on 10/24/24. SMA at 50 days reached $195.94, while 200 days put it at $221.04.
Levels Of Support And Resistance For CRL Stock
The 24-hour chart illustrates a support level at 180.92, which if violated will result in even more drops to 179.71. On the upside, there is a resistance level at 183.94. A further resistance level may holdings at 185.75. The Relative Strength Index (RSI) on the 14-day chart is 33.35, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -6.82, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 90.64%. Stochastics %K at 17.16% indicates the stock is a buying.
How much short interest is there in Charles River Laboratories International Inc.?
A steep rise in short interest was recorded in Charles River Laboratories International Inc. stocks on 2024-10-15, growing by 0.22 million shares to a total of 2.11 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 1.89 million shares. There was a rise of 10.46%, which implies that there is a positive sentiment for the stock.
